A detailed history of Prime Capital Investment Advisors, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 26,626 shares of PSNL stock, worth $102,243. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,626
Previous 27,673 3.78%
Holding current value
$102,243
Previous $32,000 346.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$1.19 - $6.34 $1,245 - $6,637
-1,047 Reduced 3.78%
26,626 $143,000
Q2 2024

Aug 08, 2024

SELL
$1.17 - $1.65 $515 - $727
-441 Reduced 1.57%
27,673 $32,000
Q1 2024

May 14, 2024

BUY
$1.15 - $2.19 $400 - $762
348 Added 1.25%
28,114 $41,000
Q4 2023

Jan 24, 2024

SELL
$0.93 - $2.35 $1,527 - $3,861
-1,643 Reduced 5.59%
27,766 $58,000
Q3 2023

Nov 09, 2023

BUY
$1.19 - $2.36 $34,996 - $69,405
29,409 New
29,409 $35,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $176M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.